Commodore Capital LP 13D/13G Filings for Bright Minds Biosciences Inc. (DRUG)

Commodore Capital LP 13D and 13G filings for Bright Minds Biosciences Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-17
4:22 pm
Sale
2025-12-3113GBRIGHT MINDS BIOSCIENCES INC C
DRUG
Commodore Capital LP18,851
0.300%
-332,997decrease
(-94.64%)
Filing
2025-02-14
4:05 pm
Purchase
2024-12-3113GBRIGHT MINDS BIOSCIENCES INC C
DRUG
Commodore Capital LP500,000
7.200%
100,000increase
(+25.00%)
Filing
2024-10-25
4:05 pm
Purchase
2024-10-1813GBRIGHT MINDS BIOSCIENCES INC C
DRUG
Commodore Capital LP400,000
9.000%
400,000increase
(New Position)
Filing